⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 1, 2026Transplantation and Cellular Therapy

Reducing Resource Utilization and Costs through a Revised Stem Cell Mobilization and Collection Algorithm in Multiple Myeloma

Tiba Al Sagheer Ariel Perez Perez Nadia M Bambace Nicolas Fernández Escobar Denise Dujon Monika Magnum Munnezzah Khan Victoria Flores Lela Hall Janelle Zayas George Nahas Jaime Roman Diaz Marco Ruiz Yuliya Linhares Guenther Koehne Harold Alvarez

View at Publisher

Ask AI

Bookmark

Share

Key Points

Resource utilization decreased significantly with the revised algorithm, improving efficiency.
The new stem cell mobilization approach is designed to enhance collection methods while minimizing costs.
Analysis of data from multiple myeloma cases highlights the effectiveness of tailored interventions.
This work suggests a model for optimizing treatment protocols in hematology, needing further evaluation in diverse settings.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

Observational analysis demonstrates reduced resource utilization in multiple myeloma, implying cost-effectiveness of the new algorithm.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sagheer et al. (2026) studied this question.

synapsesocial.com/papers/69a76066c6e9836116a2d1bb https://doi.org/10.1016/j.jtct.2025.12.313

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Significance of CD34+ Cell Dose on Outcomes of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation in AML: An Analysis Stratified by MRD StatusTransplantation and Cellular Therapy · 2026
2Exercise Prehabilitation for Older Adults Undergoing CAR-T: Feasibility, Acceptability, and Preliminary OutcomesTransplantation and Cellular Therapy · 2026
3Trends and Disparities in CAR-T Therapy Utilization, Inpatient Mortality, Length of Stay, and Costs in the United States (2017–2022)Transplantation and Cellular Therapy · 2026
4Cytomegalovirus After Autologous Hematopoietic Cell Transplantation: Impact on Outcome and A Personalized Risk-adapted Prevention StrategyTransplantation and Cellular Therapy · 2026
5Clinical trials in graft-versus-host disease: changes in study characteristics, investigated drugs, and endpoints over timeTransplantation and Cellular Therapy · 2026
6Nationwide Centralized Manufacturing and Fresh Distribution of TCRαβ/CD19-DepletedGrafts: A Real-World French ExperienceTransplantation and Cellular Therapy · 2026
7Polyomavirus-Specific T Cells in Progressive Multifocal Leukoencephalopathy: A Multicenter Retrospective AnalysisTransplantation and Cellular Therapy · 2026
8Lung Complications after Allogeneic Hematopoietic Cell Transplant and Outcomes: Implications Beyond Bronchiolitis Obliterans SyndromeTransplantation and Cellular Therapy · 2026
9A Phase Ib Study of Efmarodocokin Alfa, an Interleukin-22 Agonist, in Combination with Standard of Care, in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy · 2026
10Monospecific and Bispecific Chimeric Antigen Receptor (CAR) T-Cell Therapy in Multiple Myeloma: A Systematic Review, Meta-analysis and Meta-regressionTransplantation and Cellular Therapy · 2026

TMore from Transplantation and Cellular Therapy

More from Baptist Hospital of Miami

More from Baptist Health South Florida

More from Chinese Academy of Science and Technology for Development